mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0007 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.18 |
0.001 |